OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 60 filers reported holding OYSTER PT PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $441,226 | +124.0% | 39,501 | +12.7% | 0.00% | – |
| Q3 2022 | $197,000 | +44.9% | 35,057 | +11.7% | 0.00% | – |
| Q2 2022 | $136,000 | -88.8% | 31,393 | -70.0% | 0.00% | – |
| Q1 2022 | $1,218,000 | -39.2% | 104,673 | -4.6% | 0.00% | – |
| Q4 2021 | $2,003,000 | +52.1% | 109,720 | -1.3% | 0.00% | – |
| Q3 2021 | $1,317,000 | -35.3% | 111,139 | -6.2% | 0.00% | – |
| Q2 2021 | $2,037,000 | +21.9% | 118,505 | +29.7% | 0.00% | – |
| Q1 2021 | $1,671,000 | -13.0% | 91,392 | -10.5% | 0.00% | – |
| Q4 2020 | $1,921,000 | -8.5% | 102,075 | +2.6% | 0.00% | – |
| Q3 2020 | $2,100,000 | -21.8% | 99,492 | +7.0% | 0.00% | -100.0% |
| Q2 2020 | $2,684,000 | +11.0% | 92,961 | +34.6% | 0.00% | 0.0% |
| Q1 2020 | $2,418,000 | +50.8% | 69,089 | +5.4% | 0.00% | – |
| Q4 2019 | $1,603,000 | – | 65,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |